Anaphylaxis: A 2023 practice parameter update
David B.K. Golden(Johns Hopkins University), Dennis K. Ledford(University of South Florida), Dana Wallace(Nova Southeastern University), Anne K. Ellis(Queen's University), Ronna L. Campbell(Mayo Clinic), Matthew Greenhawt(University of Michigan), Julie Wang(Shanghai Jiao Tong University), Phil Lieberman(University of Southern California), Susan Waserman(McMaster University Medical Centre), Elissa M. Abrams(University of British Columbia), Matthew A. Rank(Mayo Clinic in Arizona), Alyssa G. Burrows(Queen's University), Caroline C. Horner(Washington University in St. Louis), Cem Akin(University of Michigan), Derek K. Chu(McMaster University), Jonathan A. Bernstein(Bernstein Clinical Research Center), John Oppenheimer(Rutgers, The State University of New Jersey), Marcus Shaker(Dartmouth College), David R. Stukus(The Ohio State University), Heather Cruickshank(The University of Queensland), David M. Lang(Cleveland Clinic)
Cited by 282
Related Papers
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
|The Lancet|2020|4.1k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k